equine health. These studies aim to address various equine health issues, including contagious upper respiratory disease, and sepsis in foals.
The research initiatives receiving support are as follows:
- Impact of cyproheptadine on blood variables and clinical signs of Pituitary Pars Intermedia Dysfunction (PPID) in Horses. (Dr. Nicholas Frank, Mississippi State University)
- Development of an effective intramuscular vaccine against strangles, based on the "S" protein of Streptococcus equi subspecies equi (SEE). (Dr. Noah Cohen, Texas A&M University.)
- A novel diagnostic test for Equine Pituitary Pars Intermedia Dysfunction (PPID).( Dr. Dianne McFarlane, University of Florida )
- Increasing understanding of foal sepsis and potential new treatment options (Dr. Katarzyna Dembek, North Carolina State University)
- Examination of a faecal-based test to aid in the diagnosis of gastric ulcers in horses (Dr. Canaan M. Whitfield-Cargile, University of Georgia)
- A study of remote behavioural and physiologic monitoring to assess changes in equine discomfort behaviours and their association with epidural morphine administration. (Dr. Hope Douglas, University of Pennsylvania)
- Investigation into drugs targeting the non-structural protein 4 of African Horse Sickness (Dr. Constantinos Kurt Wibmer, University of the Witwatersrand, South Africa )
Dr. Kathy Tietje, Chief Program Officer at Morris Animal Foundation, expressed excitement about supporting these projects, which aim to advance equine health and welfare through innovative research. The studies are scheduled to commence in the current year, contributing valuable insights to improve equid health and well-being.
For more about Morris Animal Foundation, see:
No comments:
Post a Comment